The oriGen case and Mexico’s regulatory blind spots in genomic biobanking
- 4 July 2026
- journal article
- Published by Elsevier in Trends in Biotechnology
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Community and bioethicists’ perspectives on iPSC research with biobanked samples collected using broad consentStem Cell Reports, 2025
- oriGen cohort: a Mexican population-based epidemiological and genomic research platformJournal of Epidemiology and Community Health, 2025
- MINDDS-connect: a federated data platform integrating biobanks for meta cohort building and analysisEuropean Journal of Human Genetics, 2025
- Communitarian ethics perspective on UK biobanking: the Newborn Genomes ProgrammeJournal of Medical Ethics, 2025
- A scoping review of human genetic resources management policies and databases in high- and middle-low-income countriesBMC Medical Ethics, 2025
- Mexican Biobank advances population and medical genomics of diverse ancestriesNature, 2023
- The UK Biobank resource with deep phenotyping and genomic dataNature, 2018
- Mexican Regulation of BiobanksJournal of Law, Medicine & Ethics, 2016
- Confidentiality and data sharing: vulnerabilities of the Mexican Genomics Sovereignty ActJournal of Community Genetics, 2015
- Safeguards for research using large scale DNA collectionsBMJ, 2000